GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (OTCPK:CNADF) » Definitions » Cash Ratio

CanadaBis Capital (CanadaBis Capital) Cash Ratio : 0.24 (As of Jan. 2024)


View and export this data going back to 2023. Start your Free Trial

What is CanadaBis Capital Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. CanadaBis Capital's Cash Ratio for the quarter that ended in Jan. 2024 was 0.24.

CanadaBis Capital has a Cash Ratio of 0.24. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.

The historical rank and industry rank for CanadaBis Capital's Cash Ratio or its related term are showing as below:

CNADF' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.3   Max: 250.5
Current: 0.24

During the past 8 years, CanadaBis Capital's highest Cash Ratio was 250.50. The lowest was 0.01. And the median was 0.30.

CNADF's Cash Ratio is ranked worse than
69.3% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs CNADF: 0.24

CanadaBis Capital Cash Ratio Historical Data

The historical data trend for CanadaBis Capital's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital Cash Ratio Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
Cash Ratio
Get a 7-Day Free Trial 0.24 0.02 0.08 0.01 0.33

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.30 0.33 0.36 0.24

Competitive Comparison of CanadaBis Capital's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CanadaBis Capital's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanadaBis Capital's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanadaBis Capital's Cash Ratio distribution charts can be found below:

* The bar in red indicates where CanadaBis Capital's Cash Ratio falls into.



CanadaBis Capital Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

CanadaBis Capital's Cash Ratio for the fiscal year that ended in Jul. 2023 is calculated as:

Cash Ratio (A: Jul. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=2.441/7.329
=0.33

CanadaBis Capital's Cash Ratio for the quarter that ended in Jan. 2024 is calculated as:

Cash Ratio (Q: Jan. 2024 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=1.785/7.445
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (OTCPK:CNADF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


CanadaBis Capital Cash Ratio Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (CanadaBis Capital) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.